Adverse event | No adverse event | |||||||
---|---|---|---|---|---|---|---|---|
N | M-FI | 95% CI | sd | N | M-FI | 95% CI | sd | |
Mortality | ||||||||
All | 158 | 0.28 | [0.26–0.31] | 0.14 | 3556 | 0.24 | [0.23–0.24] | 0.13 |
Men | 78 | 0.25 | [0.22–0.28] | 0.13 | 1122 | 0.23 | [0.22–0.24] | 0.13 |
Women | 80 | 0.32 | [0.28–0.35] | 0.15 | 2434 | 0.24 | [0.24–0.25] | 0.12 |
Hospitalizations | ||||||||
All | 1259 | 0.25 | [0.24–0.26] | 0.12 | 1557 | 0.23 | [0.23–0.24] | 0.12 |
Men | 424 | 0.25 | [0.24–0.26] | 0.13 | 478 | 0.22 | [0.21–0.23] | 0.12 |
Women | 835 | 0.25 | [0.24–0.26] | 0.12 | 1079 | 0.24 | [0.23–0.25] | 0.12 |
Falls | ||||||||
All | 1117 | 0.26 | [0.25–0.26] | 0.12 | 1699 | 0.23 | [0.23–0.24] | 0.12 |
Men | 343 | 0.26 | [0.24–0.27] | 0.12 | 559 | 0.21 | [0.20–0.22] | 0.12 |
Women | 774 | 0.26 | [0.25–0.27] | 0.12 | 1140 | 0.24 | [0.23–0.25] | 0.12 |